Skip to main content

Advertisement

SpringerLink
Log in

Association of sporadic breast cancer with PTEN/MMAC1/TEP1 promoter hypermethylation

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

PTEN/MMAC1/TEP1 encodes a tumor suppressor protein, which regulates cell cycle progression, translation, and apoptosis by blocking the activation of Akt/PKB. The loss of PTEN function increases cell survival and induces tumor invasion. In this study, PTEN promoter status and its correlation with genetic and pathologic parameters were analyzed in genomic DNA from Iranian patients with breast cancer. DNA methylation patterns in the CpG islands were determined by a methylation-specific PCR (MSP) assay. PTEN promoter methylation was found to be present in 37 of 53(70%) tumor tissues and none in 20 normal counterparts. Moreover, promoter methylation was found in patients with heterozygote mutation in the PTEN gene. The pathological history of cancerous tissue sections showed that PTEN gene could be inactivated at the stages III and IV in sporadic breast cancer. These findings suggested that promoter hypermethylation of PTEN might contribute to the progression of sporadic breast cancer in human.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Stambolic V, Suzuki A, Pompa JL, Brothers GM, Mirtsos C, Sasaki T, et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell. 1998;95:29–39.

    Article  PubMed  CAS  Google Scholar 

  2. Gu J, Tamura M, Pankov R, Danen EH, Takino T, Matsumoto K, et al. Shc and FAK differentially regulate cell motility and directionality modulated by PTEN. J Cell Biol. 1999;146:389–403.

    Article  PubMed  CAS  Google Scholar 

  3. Freeman DJ, Li AG, Wei G, Li H-H, Kertesz N, Lesche R, et al. PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. Cancer Cell. 2003;3:117–30.

    Article  PubMed  CAS  Google Scholar 

  4. Li AG, Piluso LG, Cai X, Wei G, Sellers WR, Liu X. Mechanistic insights into maintenance of high p53 acetylation by PTEN. Mol Cell. 2006;23:575–87.

    Article  PubMed  Google Scholar 

  5. Reifenberger J, Wolter M, Bostrom J, et al. Allelic losses on chromosome arm 10q and mutation of the PTEN (MMAC1) tumour suppressor gene in primary and metastatic malignant melanomas. Virchows Arch. 2000;436:487–93.

    Article  PubMed  CAS  Google Scholar 

  6. Piekarski JH, Biernat W. Clinical significance of CK5/6 and PTEN protein expression in patients with bilateral breast carcinoma. Histopathology. 2006;49:248–55.

    Article  PubMed  CAS  Google Scholar 

  7. Li Z, Wings TY, Chow LWC. PTEN and VEGF: possible predictors for sentinel lymph node micro-metastasis in breast cancer. Biomed Pharmacother. 2007;61:558–61.

    Article  Google Scholar 

  8. Mise-Omataa S, Obataa Y, Iwaseb S, Misec N, Doia T. Transient strong reduction of PTEN expression by specific RNAi induces loss of adhesion of the cells. Biochem Biophys Res. 2005;38:1034–42.

    Article  Google Scholar 

  9. Stambolic V, Tsao MS, Macpherson D, Suzuki A, Chapman WB, Mak TW. High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten±mice. Cancer Res. 2000;60(13):3605–11.

    PubMed  CAS  Google Scholar 

  10. Nassiri I, Tavasoli M, Faghihi M. Pharmacogenomic profiling of the PI3 K/PTEN pathway in sporadic breast cancer. Iran Biomed J. 2008;12(4):209–14.

    Google Scholar 

  11. Nassiri I, Tavasoli M, Faghihi M. Mutational analysis in the MMAC1 gene associated in patients with juvenile polyposis syndrome and cowden fisease. Austral Asian J Can. 2008;7(3):25–30.

    Google Scholar 

  12. Sehgal SN, Baker H, Vezina C. Rapamycin (AY-22, 989), a new antifungal antibiotic. II. Fermentation, isolation and characterization. J Antibiot. 1975;28:727–32.

    PubMed  CAS  Google Scholar 

  13. Singer C, Köstler W, Hudelist G. Predicting the efficacy of trastuzumab-based therapy in breast cancer: Current standards and future strategies. Biochim Biophys Acta. 2008;1786(2):105–13.

    PubMed  CAS  Google Scholar 

  14. Sambrook J, Fritsh EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 2001.

    Google Scholar 

  15. Miller SA, Dykes DD, Polesky HF. A simple salting-out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.

    Article  PubMed  CAS  Google Scholar 

  16. Zysman MA, Chapman WB, Bharati B. Considerations when analyzing the methylation status of PTEN tumor suppressor gene. Am J Pathol. 2002;160:795–800.

    Article  PubMed  CAS  Google Scholar 

  17. Baker SJ. PTEN enters the nuclear age. Cell. 2007;128:25–8.

    Article  PubMed  CAS  Google Scholar 

  18. Bose S, Crane A, Hibshoosh H, Mansukhani M, Sandweis L, Parsons R. Reduced expression of PTEN correlates with breast cancer progression. Hum Pathol. 2002;33:405–9.

    Article  PubMed  CAS  Google Scholar 

  19. Khan K, Umagal K, Vora J, Bose N, Sehgal S, Koeffler E, et al. PTEN promoter is methylated in a proportion of invasive breast cancer. Int J Cancer. 2004;112:407–10.

    Article  PubMed  CAS  Google Scholar 

  20. Kang Y, Lee HS, Ho KW. Promoter methylation and silencing of PTEN in gastric carcinoma. Lab Invest. 2002;82:285–91.

    PubMed  CAS  Google Scholar 

  21. Chang S, Lee SN, Cho MS, Koo H, Han WS, Im SA, et al. Loss of PTEN expression in breast cancers. Korean J Path. 2005;39:236–41.

    Google Scholar 

Download references

Acknowledgments

The authors wish to thank Dr M Faghihi from breast cancer section of the Seyed Al-Shohada Hospital, Isfahan, IR, for providing the normal and breast carcinoma tissues. This work was supported through a general grant (Pajoohaneh) by the department of research of University of Isfahan to S Vallian.

Author information

Authors and Affiliations

  1. Division of Genetics, Department of Biology, Faculty of Science, University of Isfahan, Hezarjerib St., Isfahan, Islamic Republic of Iran

    Vallian Sadeq, Nassiri Isar & Tavassoli Manoochehr

Authors
  1. Vallian Sadeq
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nassiri Isar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tavassoli Manoochehr
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vallian Sadeq.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sadeq, V., Isar, N. & Manoochehr, T. Association of sporadic breast cancer with PTEN/MMAC1/TEP1 promoter hypermethylation. Med Oncol 28, 420–423 (2011). https://doi.org/10.1007/s12032-010-9473-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12032-010-9473-8

Keywords

Search

Navigation